![Bent Frandsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bent Frandsen
Directeur Général chez
EXPRES2ION BIOTECH HOLDING AB
Profil
Bent U.
Frandsen currently works at ExpreS2ion Biotechnologies ApS, as Chief Executive Officer and Expres2ion Biotech Holding AB, as Chief Executive Officer from 2019.
Mr. Frandsen also formerly worked at Adaptvac ApS, as Director and NsGene A, as Vice President-Business Development.
Mr. Frandsen received his graduate degree in 1993 from Copenhagen Business School.
Postes actifs de Bent Frandsen
| Sociétés | Poste | Début |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur Général | 20/12/2019 |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Directeur Général | - |
Anciens postes connus de Bent Frandsen
| Sociétés | Poste | Fin |
|---|---|---|
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Corporate Officer/Principal | - |
Adaptvac ApS
 Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Directeur/Membre du Conseil | - |
Formation de Bent Frandsen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
Adaptvac ApS
Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Health Technology |
